Animal and Veterinary Innovation Centers
Funds academic institutions to become long-term FDA partners researching bird flu, animal genomics and unmet veterinary needs.
Avian flu, genomic engineering in animals, and drugs for minor species or unmet veterinary needs all sit at the edge of what any single lab can tackle alone, and FDA's Center for Veterinary Medicine (CVM) wants standing research partners rather than one-off grants for this work.
This funds Animal and Veterinary Innovation Centers — long-term cooperative-agreement partnerships between CVM and acad…
Long-term cooperative-agreement partnerships between FDA's Center for Veterinary Medicine and academic research institutions to drive research on Highly Pathogenic Avian Influenza in animals, intentional genomic alterations in animals supporting agricultural resilience and animal or public health, and products for minor species or minor uses in major species and other unmet veterinary needs.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportSAM.gov Registration and UEI Guide for Federal Grant Applicants
Learn how SAM.gov registration, UEI numbers, Grants.gov accounts, organization profiles, workspace roles, and renewal timing fit together.
BudgetIndirect Costs in Grants: Rates, MTDC, and Examples
Understand indirect costs in grants, including direct vs indirect costs, negotiated rates, de minimis rates, MTDC, funder caps, and budget narrative implications.
More from FDA
All grants from this funder →Minor Use Minor Species Development of Drugs
FDA · United States
Funds the safety and effectiveness testing costs of getting a designated new animal drug through FDA approval.
Laboratory Flexible Funding Model (LFFM)
🇺🇸FDA · United States
Funds state, territorial and tribal food- and animal-testing laboratories to run sample testing and lab capacity work for FDA's food safety system.
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
FDA · United States
Funds natural history studies that track how a rare disease unfolds over time, to close data gaps blocking new treatments for it.
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
FDA · United States
Funds clinical trials testing whether a product works and is safe for a rare disease, aimed at a new indication or a labeling change.
Vet-LIRN Capacity-Building Project and Equipment Grants
🇺🇸FDA · United States
Funds equipment and capacity-building projects for veterinary diagnostic labs fighting animal-food hazards and drug resistance.
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
FDA · United States
Funds foreign and domestic entities running rare-disease clinical trials through FDA orphan products research grants.
Similar grants
Browse the directory →
NOAA-wide BAA FY
🇺🇸NOAA · United States
Supports research, education, and outreach across NOAA domains when no other program fits.
GREGoRi Data Coordination and Outreach Center
🇺🇸NIH · United States
Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
🇺🇸CDC · United States
Funds surveillance and research networks that detect, diagnose and track infectious diseases among international travelers.
Bioengineering Partnerships with Industry (BPI)
🇺🇸NIBIB · United States
Funds academia-industry partnerships for biomedical engineering development with sustained milestones and shared commercialization planning.
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2
🇺🇸NIH · United States
Funds single-cell research into how opioid use and HIV interact in brain tissue, building on the SCORCH consortium's first phase.